Distal Radial Fractures in Adult Patients: 4 Weeks Versus 6 Weeks of Cast Immobilization

NCT ID: NCT07234370

Last Updated: 2025-11-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-15

Study Completion Date

2026-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Post-intervention outcomes comparing casting in distal radius fractures of four weeks versus six weeks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cast immobilization for 6 weeks remains the mainstay of therapy for distal radius fractures. To challenge the therapeutic time frame, participants will be randomized into two arms, and the treatment arm will undergo immobilization for 4 weeks. Outcomes will be assessed at cast removal and then at 3 and 6 months prospectively using the Quick-DASH score and the DASH score (only at 6 months).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fracture Forearm Radius Distal Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cast immobilization for four weeks

Scotch cast immobilization for a period of four weeks applied to distal radius fractures.

Group Type EXPERIMENTAL

Short Arm Cast for Distal Radius Fracture for four weeks

Intervention Type PROCEDURE

Scotch cast immobilization below elbow for four weeks

Cast immobilization for six weeks

Scotch cast immobilization for a period of six weeks applied to distal radius fractures

Group Type ACTIVE_COMPARATOR

Short Arm Cast for Distal Radius Fracture for six weeks

Intervention Type PROCEDURE

Scotch cast immobilization below elbow for six weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Short Arm Cast for Distal Radius Fracture for four weeks

Scotch cast immobilization below elbow for four weeks

Intervention Type PROCEDURE

Short Arm Cast for Distal Radius Fracture for six weeks

Scotch cast immobilization below elbow for six weeks

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Splint Cast Splint Cast

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with DRF undergoing conservative management with cast immobilization
* Age between 18 to 50 years.

Exclusion Criteria

* Any syndromic patients
* Any patients with musculoskeletal disease
* Patients having osteoporosis
* Post-menopausal females
* Smokers
* Ages less than 18 or greater than 50
* Patients presenting with intra-articular fractures
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Liaquat National Hospital & Medical College

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohammad Zeeshan Haider

Resident Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohammad Nabeel Aamir Syed, MBBS, MD

Role: PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Liaquat National Hospital

Karachi, Sindh, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R.C-LNH-Orthpedics-05/2025/52

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.